Pressure BioSciences, Inc. Stock Nasdaq
Equities
US74112E1091
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2022 | 1.73M | Sales 2023 | 1.98M | Capitalization | 7.77M |
---|---|---|---|---|---|
Net income 2022 | -16M | Net income 2023 | -29M | EV / Sales 2022 | 21.1 x |
Net Debt 2022 | 20.53M | Net Debt 2023 | 22.8M | EV / Sales 2023 | 15.5 x |
P/E ratio 2022 |
-0.81
x | P/E ratio 2023 |
-0.22
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.34% |
Latest transcript on Pressure BioSciences, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 73 | 78-07-31 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 70 | 06-04-23 |
Chief Tech/Sci/R&D Officer | 59 | 06-04-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 73 | 78-07-31 | |
Michael Urdea
BRD | Director/Board Member | 71 | 13-02-07 |
Jeffrey Peterson
CHM | Chairman | 68 | 11-06-20 |
1st Jan change | Capi. | |
---|---|---|
-5.31% | 181B | |
-5.38% | 99.95B | |
-6.04% | 66.21B | |
+16.45% | 45.4B | |
-8.08% | 45.36B | |
+8.38% | 43.84B | |
+12.06% | 29.03B | |
+17.98% | 25.64B | |
-8.28% | 23.53B |